SignalCorporate
CeriBell outlines $115M-$117M 2026 revenue, while launching delirium monitoring and previewing Omni for 2027
CeriBell outlines $115M-$117M 2026 revenue, while launching delirium monitoring and previewing Omni for 2027
Context
What happened: CeriBell outlined 2026 revenue guidance of $115M to $117M, said it is launching delirium monitoring, and previewed Omni for 2027.
Key numbers: Q3 revenue $29.3 million, up approximately 30% year-over-year. 2026 revenue guidance $115M to $117M.
Why it matters: Management tied the quarter to adoption and commercial execution, and the guidance plus new product launches point to planned expansion beyond the current portfolio.
What changed
CeriBell outlined 2026 revenue guidance of $115M to $117M, said it is launching delirium monitoring, and previewed Omni for 2027.
Why it matters
Management tied the quarter to adoption and commercial execution, and the guidance plus new product launches point to planned expansion beyond the current portfolio.